Literature DB >> 6217745

Acupuncture treatment of chronic back pain. A double-blind placebo-controlled trial.

G Mendelson, T S Selwood, H Kranz, T S Loh, M A Kidson, D S Scott.   

Abstract

Acupuncture treatment of chronic low back pain was studied in a placebo-controlled double-blind crossover trial completed by 77 patients. The patients had significantly increased depression, neuroticism, and hypochondriasis scores. Initial pain levels correlated with state-anxiety, depression, pain duration, and abnormal illness behavior measures, as well as with the intake of psychotropic but not analgesic medication. Overall reduction in pain score was 26 percent for acupuncture and 22 percent for placebo treatment; the difference was not significant (p greater than 0.6). Analgesic drug intake was reduced to a similar extent in both groups. During the first phase of treatment, patients receiving acupuncture had a greater but not significantly different reduction in pain rating scores compared with those receiving placebo (t = 0.52; p greater than 0.6). This group showed significantly lower pain scores (p less than 0.05) in the second phase of the trial while receiving placebo treatment. Overall reduction in individual patient's pain score was best predicted by initial pain severity (r = 0.43; p less than 0.001) and psychotropic drug intake (r = 0.37; p less than 0.001). None of the variables tested predicted which patients would specifically respond to acupuncture or placebo.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6217745     DOI: 10.1016/0002-9343(83)91117-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  15 in total

1.  A systematic review and meta-analysis of efficacy, cost-effectiveness, and safety of selected complementary and alternative medicine for neck and low-back pain.

Authors:  Andrea D Furlan; Fatemeh Yazdi; Alexander Tsertsvadze; Anita Gross; Maurits Van Tulder; Lina Santaguida; Joel Gagnier; Carlo Ammendolia; Trish Dryden; Steve Doucette; Becky Skidmore; Raymond Daniel; Thomas Ostermann; Sophia Tsouros
Journal:  Evid Based Complement Alternat Med       Date:  2011-11-24       Impact factor: 2.629

2.  Individual recovery expectations and prognosis of outcomes in non-specific low back pain: prognostic factor review.

Authors:  Jill A Hayden; Maria N Wilson; Richard D Riley; Ross Iles; Tamar Pincus; Rachel Ogilvie
Journal:  Cochrane Database Syst Rev       Date:  2019-11-25

3.  Effect sizes of non-surgical treatments of non-specific low-back pain.

Authors:  A Keller; J Hayden; C Bombardier; M van Tulder
Journal:  Eur Spine J       Date:  2007-07-10       Impact factor: 3.134

Review 4.  Imperfect placebos are common in low back pain trials: a systematic review of the literature.

Authors:  L A C Machado; S J Kamper; R D Herbert; C G Maher; J H McAuley
Journal:  Eur Spine J       Date:  2008-04-18       Impact factor: 3.134

Review 5.  Responder analyses in randomised controlled trials for chronic low back pain: an overview of currently used methods.

Authors:  Nicholas Henschke; Annefloor van Enst; Robert Froud; Raymond W G Ostelo
Journal:  Eur Spine J       Date:  2014-01-14       Impact factor: 3.134

Review 6.  How effective is acupuncture in the management of pain?

Authors:  G T Lewith
Journal:  J R Coll Gen Pract       Date:  1984-05

7.  Acupuncture.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-30

8.  Can we assess the effects of acupuncture?

Authors:  G T Lewith
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-19

9.  An international expert survey on acupuncture in randomized controlled trials for low back pain and a validation of the low back pain acupuncture score.

Authors:  Albrecht Molsberger; J Zhou; L Boewing; D Arndt; M Karst; W Teske; A Drabik
Journal:  Eur J Med Res       Date:  2011-03-28       Impact factor: 2.175

10.  The Universality of Science and Traditional Chinese Medicine: A Philosophical Survey.

Authors:  Íñigo Ongay de Felipe
Journal:  Sci Educ (Dordr)       Date:  2021-06-25       Impact factor: 2.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.